200 related articles for article (PubMed ID: 34162604)
1. Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis.
Englert P; Levy S; Vekemans M; De Wilde V
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34162604
[TBL] [Abstract][Full Text] [Related]
2. Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.
Chinen Y; Nakao M; Sugitani-Yamamoto M; Kiyota M; Horiike S; Kuroda J; Taniwaki M
Int J Hematol; 2011 Dec; 94(6):567-70. PubMed ID: 22045306
[TBL] [Abstract][Full Text] [Related]
3. Lactic acidosis: a unique presentation of diffuse large B-cell lymphoma.
Mohammed TJ; Gosain R; Sharma R; Torka P
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31653622
[TBL] [Abstract][Full Text] [Related]
4. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
[TBL] [Abstract][Full Text] [Related]
6. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
7. DLBCL developed into fatal liver failure during rituximab-containing chemotherapy.
Shimazu Y; Nohgawa M
J Clin Exp Hematop; 2019; 59(2):93-95. PubMed ID: 31257349
[No Abstract] [Full Text] [Related]
8. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Osorio S; Bernis C; de La Cámara R
Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
[No Abstract] [Full Text] [Related]
9. Rare case of primary bone lymphoma of the femur.
Kiamos A; Boldig K; Gagadam V; Gujarathi R
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474139
[TBL] [Abstract][Full Text] [Related]
10. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
[No Abstract] [Full Text] [Related]
11. Successful multidisciplinary management of an asymptomatic gastrosplenic fistula in a diffuse large B cell lymphoma patient.
Mansouri S; Assane C; Malo FC
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256358
[TBL] [Abstract][Full Text] [Related]
12. Primary Lymphoma of Liver-a Rare Space-Occupying Lesion.
Patkar S; Dutt K; Shah A; Sengar M; Goel M
J Gastrointest Cancer; 2020 Sep; 51(3):1057-1060. PubMed ID: 32333249
[No Abstract] [Full Text] [Related]
13. Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.
Tekinalp A; Kars TU; Dikici HZ; Yılmaz PD; Demircioğlu S; Çeneli Ö
J Oncol Pharm Pract; 2022 Mar; 28(2):449-452. PubMed ID: 34549658
[TBL] [Abstract][Full Text] [Related]
14. Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
Abramson JS
Cancer; 2019 Sep; 125(18):3111-3120. PubMed ID: 31287161
[TBL] [Abstract][Full Text] [Related]
15. Primary cardiac lymphoma.
Chia AXF; Zhao Z; Lim SL
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31796452
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma presented as dysphagia: a diagnosis hard to swallow.
João M; Bento-Miranda M; Gravito-Soares E; Gravito-Soares M; Figueiredo P
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972779
[TBL] [Abstract][Full Text] [Related]
17. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Tian C; Chen Z; Li Y
J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Successful Intensive Care Treatment of Severe Lactic Acidosis and Tumor Lysis Syndrome Related to Intravascular Lymphoma.
Mase H; Ogawa Y; Takeuchi J; Genda Y; Ichiba S; Sakamoto A
J Nippon Med Sch; 2020 Mar; 87(1):32-36. PubMed ID: 31308316
[TBL] [Abstract][Full Text] [Related]
20. Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement.
Kojima M; Amaki J; Ogiya D; Ando K; Nakamura N
J Clin Exp Hematop; 2020 Jun; 60(2):60-61. PubMed ID: 32404573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
